US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Veracyte

41.47

-0.8400-1.99%

Post-market: 41.470.00000.00%17:31 EDT

Volume:1.17M

Turnover:48.28M

Market Cap:3.33B

PE:29.74

High:42.07

Open:42.00

Low:41.02

Close:42.31

52wk High:60.91

52wk Low:28.25

Shares:80.39M

Float Shares:78.97M

Volume Ratio:0.90

T/O Rate:1.48%

Dividend:- -

Dividend Rate:- -

EPS(TTM):1.39

EPS(LYR):0.8200

ROE:8.77%

ROA:4.09%

PB:2.40

PE(LYR):50.57

Loading ...

Overview Company News Filings

Veracyte (VCYT) Stock Could Be 4.5% Overvalued After Its Recent Run

Simply Wall St.

Veracyte shareholders endorse board, pay and incentive plans

Veracyte shareholders approve 3.5 million-share increase to 2023 equity plan at annual meeting

Veracyte EVP, General Counsel Annie McGuire disposes of common shares worth $159,490

Veracyte CFO Rebecca Chambers disposes of 3,561 common shares worth $177,866.63

Veracyte CEO Marc Stapley disposes of common shares worth $7.35 million

Veracyte Global Chief Commercial Officer John Leite disposes of USD 700,732 in common shares

Veracyte posts investor presentation outlining growth strategy for genomic cancer diagnostics portfolio

Needham Raises Price Target on Veracyte to $57 From $48, Keeps Buy Rating

MT Newswires Live

Veracyte assumed with an Outperform at Wolfe Research

Veracyte Is Maintained at Buy by Needham

Veracyte Inc : Needham Raises Target Price to $57 From $48

THOMSON REUTERS

Veracyte posts investor presentation on ASCO findings

Veracyte announces results from Enzamet trial presented at 2026 ASCO meeting

Veracyte - Enzamet Trial Shows Decipher Prostate Test Identifies Chemotherapy Benefit in Metastatic Prostate Cancer

THOMSON REUTERS

Veracyte says ENZAMET trial shows Decipher Prostate test flags metastatic patients who benefit from adding docetaxel

Veracyte Says Prosigna Test Can Help High-Risk Breast Cancer Patients Avoid Chemotherapy

MT Newswires Live

Veracyte says OPTIMA trial shows Prosigna test helps 68% of high-risk breast cancer patients avoid chemotherapy

Veracyte - Optima Trial Shows Prosigna Test Identifies High-Risk Breast Cancer Patients Who Can Avoid Chemotherapy

THOMSON REUTERS

Veracyte Price Target Maintained With a $48.00/Share by Needham

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.etasphere.com/stock/VCYT/news?page=3"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"VCYT","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"VCYT\",,,,,undefined,":{"symbol":"VCYT","market":"US","secType":"STK","nameCN":"Veracyte","latestPrice":41.47,"timestamp":1787601600000,"preClose":42.31,"halted":0,"volume":1165420,"hourTrading":{"tag":"盘后","latestPrice":41.47,"preClose":41.47,"latestTime":"17:31 EDT","volume":86354,"amount":3581031.2968,"timestamp":1787607081586,"change":0,"changeRate":0,"amplitude":0.010369},"delay":0,"changeRate":-0.019853462538407075,"floatShares":78966096,"shares":80390731,"eps":1.394338,"marketStatus":"Post-Mkt","change":-0.84,"latestTime":"08-24 18:04:55 EDT","open":42,"high":42.067,"low":41.02,"amount":48278584.0322,"amplitude":0.024746,"askPrice":42.01,"askSize":99,"bidPrice":41.13,"bidSize":99,"shortable":3,"etf":0,"ttmEps":1.394338,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1787616000000},"marketStatusCode":4,"adr":0,"adrRate":0,"listingDate":1383105600000,"exchange":"NASDAQ","adjPreClose":42.31,"preHourTrading":{"tag":"盘前","latestPrice":42.31,"preClose":42.31,"latestTime":"09:15 EDT","volume":4987,"amount":211027.61792800002,"timestamp":1787577311623,"change":0,"changeRate":0,"amplitude":0.00489},"postHourTrading":{"tag":"盘后","latestPrice":41.47,"preClose":41.47,"latestTime":"17:31 EDT","volume":86354,"amount":3581031.2968,"timestamp":1787607081586,"change":0,"changeRate":0,"amplitude":0.010369},"volumeRatio":0.90125,"impliedVol":0.6405,"impliedVolPercentile":0.7809},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"VCYT\",,,,,undefined,":{"symbol":"VCYT","floatShares":78966096,"roa":"4.09%","roe":"8.77%","lyrEps":0.82,"volumeRatio":0.90125,"shares":80390731,"dividePrice":0,"high":42.067,"amplitude":0.024746,"preClose":42.31,"low":41.02,"week52Low":28.25,"pbRate":"2.40","psRate":"5.93","week52High":60.91,"institutionHeld":0,"latestPrice":41.47,"eps":1.394338,"divideRate":0,"volume":1165420,"delay":0,"ttmEps":1.394338,"open":42,"prevYearClose":42.1,"prevWeekClose":42.31,"prevMonthClose":46.32,"prevQuarterClose":58.73,"fiveDayClose":42.08,"twentyDayClose":55.61,"sixtyDayClose":47.99},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/VCYT\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-07-30","symbol":"VCYT","fiscalQuarterEnding":"2026/06","expectedEps":0.29,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1785384000000,"reportTimeType":"post","actualEps":0.37},{"market":"US","date":"2026-05-05","symbol":"VCYT","fiscalQuarterEnding":"2026/03","expectedEps":0.23,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1777953600000,"reportTimeType":"post","actualEps":0.37},{"market":"US","date":"2026-02-25","symbol":"VCYT","fiscalQuarterEnding":"2025/12","expectedEps":0.28,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1771995600000,"reportTimeType":"post","actualEps":0.4},{"market":"US","date":"2026-01-11","symbol":"VCYT","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1768107600000,"reportTimeType":"post","actualEps":null},{"market":"US","date":"2025-11-04","symbol":"VCYT","fiscalQuarterEnding":"2025/09","expectedEps":0.19,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1762232400000,"reportTimeType":"post","actualEps":0.38}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"VCYT\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"VCYT\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.4615,"buy":0.3846,"hold":0.0769,"sell":0.0769,"strongSell":0,"meanLabel":"BUY","meanPercent":0.3846,"analysts":13,"updateTime":1784174400000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/VCYT\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"VCYT","date":"2026-08-21","current":29.713025,"percent":0.695652,"low":-385.825732,"twenty":-48.918745,"median":-29.203367,"eighty":57.374001,"high":128.754434,"avg":-22.227529,"sd":98.989589,"marketCap":3359528648},"quantilePoints":[{"date":"2021-08-27","current":-53.606041,"twenty":-91.262492,"median":-35.194187,"eighty":-7.388517,"marketCap":3381147439},{"date":"2021-09-03","current":-57.582684,"twenty":-91.262492,"median":-36.123643,"eighty":-7.400246,"marketCap":3631970196},{"date":"2021-09-10","current":-54.661986,"twenty":-91.262492,"median":-36.714132,"eighty":-7.411536,"marketCap":3447750092},{"date":"2021-09-17","current":-57.515283,"twenty":-91.262492,"median":-37.282622,"eighty":-7.433589,"marketCap":3627718963},{"date":"2021-09-24","current":-54.909122,"twenty":-91.262492,"median":-37.675398,"eighty":-7.452597,"marketCap":3463337947},{"date":"2021-10-01","current":-52.437762,"twenty":-91.262492,"median":-37.857434,"eighty":-7.469818,"marketCap":3307459398},{"date":"2021-10-08","current":-46.652533,"twenty":-91.262492,"median":-38.378258,"eighty":-7.482161,"marketCap":2942561885},{"date":"2021-10-15","current":-50.730277,"twenty":-91.262492,"median":-38.729689,"eighty":-7.508673,"marketCap":3199761491},{"date":"2021-10-22","current":-52.123225,"twenty":-91.262492,"median":-39.246498,"eighty":-7.518204,"marketCap":3287620310},{"date":"2021-10-29","current":-53.785776,"twenty":-91.262492,"median":-39.473894,"eighty":-7.52613,"marketCap":3392484061},{"date":"2021-11-05","current":-56.122335,"twenty":-91.262492,"median":-39.856333,"eighty":-7.536946,"marketCap":3539860144},{"date":"2021-11-12","current":-46.808569,"twenty":-91.262492,"median":-40.393814,"eighty":-7.546315,"marketCap":3420723435},{"date":"2021-11-19","current":-47.926531,"twenty":-91.262492,"median":-40.827934,"eighty":-7.571063,"marketCap":3502422956},{"date":"2021-11-26","current":-40.402163,"twenty":-91.262492,"median":-41.146277,"eighty":-7.587331,"marketCap":2952549656},{"date":"2021-12-03","current":-35.084554,"twenty":-91.262492,"median":-41.146277,"eighty":-7.618881,"marketCap":2563944107},{"date":"2021-12-10","current":-38.127354,"twenty":-91.262492,"median":-41.146277,"eighty":-7.640848,"marketCap":2786308891},{"date":"2021-12-17","current":-43.736605,"twenty":-91.262492,"median":-41.231045,"eighty":-7.697542,"marketCap":3196227359},{"date":"2021-12-23","current":-39.361972,"twenty":-91.262492,"median":-41.315975,"eighty":-7.725635,"marketCap":2876533580},{"date":"2021-12-31","current":-40.052192,"twenty":-91.262492,"median":-41.315975,"eighty":-7.746237,"marketCap":2926974154},{"date":"2022-01-07","current":-32.644481,"twenty":-91.224661,"median":-41.320023,"eighty":-7.765318,"marketCap":2385626021},{"date":"2022-01-14","current":-29.494745,"twenty":-91.224661,"median":-41.320023,"eighty":-7.800551,"marketCap":2155446501},{"date":"2022-01-21","current":-26.20891,"twenty":-91.224661,"median":-41.320023,"eighty":-7.817638,"marketCap":1915320951},{"date":"2022-01-28","current":-26.325567,"twenty":-91.224661,"median":-41.320023,"eighty":-7.877447,"marketCap":1923846118},{"date":"2022-02-04","current":-27.861549,"twenty":-91.224661,"median":-41.320023,"eighty":-7.937202,"marketCap":2036094156},{"date":"2022-02-11","current":-29.105889,"twenty":-91.224661,"median":-41.320023,"eighty":-8.057858,"marketCap":2127029276},{"date":"2022-02-18","current":-24.624321,"twenty":-91.224661,"median":-41.320023,"eighty":-8.118793,"marketCap":1799520760},{"date":"2022-02-25","current":-26.179746,"twenty":-91.224661,"median":-41.320023,"eighty":-8.137105,"marketCap":1913189659},{"date":"2022-03-04","current":-23.336354,"twenty":-91.224661,"median":-41.320023,"eighty":-8.153724,"marketCap":1763364885},{"date":"2022-03-11","current":-22.422126,"twenty":-91.224661,"median":-41.320023,"eighty":-8.153724,"marketCap":1694283142},{"date":"2022-03-18","current":-26.663386,"twenty":-91.224661,"median":-41.320023,"eighty":-8.153724,"marketCap":2014765452},{"date":"2022-03-25","current":-25.409858,"twenty":-91.224661,"median":-41.320023,"eighty":-8.153724,"marketCap":1920045125},{"date":"2022-04-01","current":-27.351413,"twenty":-91.224661,"median":-41.320023,"eighty":-8.153724,"marketCap":2066754804},{"date":"2022-04-08","current":-24.297706,"twenty":-91.224661,"median":-41.320023,"eighty":-8.153724,"marketCap":1836007541},{"date":"2022-04-14","current":-22.761427,"twenty":-91.224661,"median":-41.320023,"eighty":-8.153724,"marketCap":1719921727},{"date":"2022-04-22","current":-20.537122,"twenty":-91.224661,"median":-41.320023,"eighty":-8.178289,"marketCap":1551846560},{"date":"2022-04-29","current":-19.354001,"twenty":-91.224661,"median":-41.320023,"eighty":-8.181561,"marketCap":1462446398},{"date":"2022-05-06","current":-27.358006,"twenty":-91.224661,"median":-41.320023,"eighty":-8.208642,"marketCap":1317452124},{"date":"2022-05-13","current":-26.942591,"twenty":-91.224661,"median":-41.320023,"eighty":-8.276391,"marketCap":1297447428},{"date":"2022-05-20","current":-27.254152,"twenty":-91.224661,"median":-41.320023,"eighty":-8.366376,"marketCap":1312450950},{"date":"2022-05-27","current":-28.025636,"twenty":-91.224661,"median":-41.320023,"eighty":-8.476091,"marketCap":1349602529},{"date":"2022-06-03","current":-25.399624,"twenty":-91.224661,"median":-41.320023,"eighty":-8.585431,"marketCap":1223144272},{"date":"2022-06-10","current":-24.227561,"twenty":-91.224661,"median":-41.320023,"eighty":-8.77283,"marketCap":1166702451},{"date":"2022-06-17","current":-25.221589,"twenty":-91.224661,"median":-41.320023,"eighty":-9.855819,"marketCap":1214570831},{"date":"2022-06-24","current":-33.737584,"twenty":-91.262492,"median":-41.324071,"eighty":-10.019151,"marketCap":1624667099},{"date":"2022-07-01","current":-31.304443,"twenty":-91.262492,"median":-41.324071,"eighty":-10.565025,"marketCap":1507496737},{"date":"2022-07-08","current":-37.980745,"twenty":-91.262492,"median":-41.324071,"eighty":-10.960462,"marketCap":1829000780},{"date":"2022-07-15","current":-39.597894,"twenty":-91.262492,"median":-41.324071,"eighty":-11.08511,"marketCap":1906876204},{"date":"2022-07-22","current":-36.408105,"twenty":-91.262492,"median":-41.324071,"eighty":-11.633973,"marketCap":1753268717},{"date":"2022-07-29","current":-39.078626,"twenty":-91.262492,"median":-41.324071,"eighty":-12.082717,"marketCap":1881870334},{"date":"2022-08-05","current":-41.047649,"twenty":-91.262492,"median":-41.324071,"eighty":-12.243479,"marketCap":1996968112},{"date":"2022-08-12","current":-38.325851,"twenty":-91.262492,"median":-41.324071,"eighty":-12.587971,"marketCap":1864552663},{"date":"2022-08-19","current":-31.925949,"twenty":-91.262492,"median":-41.324071,"eighty":-12.988602,"marketCap":1553197420},{"date":"2022-08-26","current":-31.396302,"twenty":-91.262492,"median":-41.324071,"eighty":-13.149364,"marketCap":1527430090},{"date":"2022-09-02","current":-28.218419,"twenty":-91.262492,"median":-41.324071,"eighty":-13.540343,"marketCap":1372826107},{"date":"2022-09-09","current":-29.351276,"twenty":-91.262492,"median":-41.324071,"eighty":-13.833244,"marketCap":1427939564},{"date":"2022-09-16","current":-27.173838,"twenty":-91.262492,"median":-41.324071,"eighty":-14.159873,"marketCap":1322007205},{"date":"2022-09-23","current":-24.393191,"twenty":-91.262492,"median":-41.324071,"eighty":-14.478846,"marketCap":1186728720},{"date":"2022-09-30","current":-24.422615,"twenty":-91.262492,"median":-41.324071,"eighty":-14.790164,"marketCap":1188160238},{"date":"2022-10-07","current":-25.84972,"twenty":-91.262492,"median":-41.324071,"eighty":-15.050446,"marketCap":1257588879},{"date":"2022-10-14","current":-22.966086,"twenty":-91.262492,"median":-41.324071,"eighty":-15.25459,"marketCap":1117300079},{"date":"2022-10-21","current":-23.289759,"twenty":-91.262492,"median":-41.324071,"eighty":-15.583771,"marketCap":1133046781},{"date":"2022-10-28","current":-28.409681,"twenty":-91.262492,"median":-41.324071,"eighty":-15.919051,"marketCap":1382130976},{"date":"2022-11-04","current":-40.452678,"twenty":-91.262492,"median":-41.324071,"eighty":-16.688819,"marketCap":1749335604},{"date":"2022-11-11","current":-49.678145,"twenty":-91.262492,"median":-41.386088,"eighty":-17.169567,"marketCap":2148281706},{"date":"2022-11-18","current":-43.107489,"twenty":-91.262492,"median":-41.758191,"eighty":-17.412803,"marketCap":1864140238},{"date":"2022-11-25","current":-43.472525,"twenty":-91.262492,"median":-42.093687,"eighty":-17.842042,"marketCap":1879925875},{"date":"2022-12-02","current":-48.35074,"twenty":-91.262492,"median":-42.327795,"eighty":-18.10817,"marketCap":2090879389},{"date":"2022-12-09","current":-44.285561,"twenty":-91.262492,"median":-42.974748,"eighty":-18.75489,"marketCap":1915084794},{"date":"2022-12-16","current":-45.480226,"twenty":-91.262492,"median":-43.472525,"eighty":-19.425491,"marketCap":1966746879},{"date":"2022-12-23","current":-40.784529,"twenty":-91.262492,"median":-43.720153,"eighty":-19.972499,"marketCap":1763686183},{"date":"2022-12-30","current":-39.374161,"twenty":-91.262492,"median":-43.720153,"eighty":-20.35166,"marketCap":1702696222},{"date":"2023-01-06","current":-37.150757,"twenty":-91.262492,"median":-43.720153,"eighty":-20.503192,"marketCap":1606547341},{"date":"2023-01-13","current":-44.169413,"twenty":-91.262492,"median":-43.732402,"eighty":-20.769453,"marketCap":1910062091},{"date":"2023-01-20","current":-41.298899,"twenty":-91.262492,"median":-43.736605,"eighty":-21.742511,"marketCap":1785929581},{"date":"2023-01-27","current":-43.190451,"twenty":-91.262492,"median":-43.736605,"eighty":-22.438376,"marketCap":1867727882},{"date":"2023-02-03","current":-44.252376,"twenty":-91.262492,"median":-43.837562,"eighty":-22.780131,"marketCap":1913649736},{"date":"2023-02-10","current":-40.4029,"twenty":-91.262492,"median":-43.837562,"eighty":-22.930786,"marketCap":1747183017},{"date":"2023-02-17","current":-42.244675,"twenty":-91.262492,"median":-43.84417,"eighty":-23.317716,"marketCap":1826828732},{"date":"2023-02-24","current":-46.670784,"twenty":-91.262492,"median":-43.920524,"eighty":-23.6458,"marketCap":1706283866},{"date":"2023-03-03","current":-48.823359,"twenty":-91.262492,"median":-44.252376,"eighty":-23.913066,"marketCap":1784981994},{"date":"2023-03-10","current":-41.620236,"twenty":-91.262492,"median":-44.319889,"eighty":-24.309016,"marketCap":1521635823},{"date":"2023-03-17","current":-44.26467,"twenty":-91.262492,"median":-44.699024,"eighty":-24.439109,"marketCap":1618316335},{"date":"2023-03-24","current":-43.356879,"twenty":-91.262492,"median":-44.721105,"eighty":-24.592861,"marketCap":1585127502},{"date":"2023-03-31","current":-44.00812,"twenty":-91.224661,"median":-44.710065,"eighty":-24.693937,"marketCap":1608936882},{"date":"2023-04-06","current":-42.409619,"twenty":-91.224661,"median":-44.710065,"eighty":-24.843197,"marketCap":1550495677},{"date":"2023-04-14","current":-44.99485,"twenty":-91.262492,"median":-44.721105,"eighty":-25.139143,"marketCap":1645011700},{"date":"2023-04-21","current":-45.001813,"twenty":-91.262492,"median":-44.881973,"eighty":-25.257948,"marketCap":1645266294},{"date":"2023-04-28","current":-44.130683,"twenty":-91.262492,"median":-44.971343,"eighty":-25.392408,"marketCap":1613417760},{"date":"2023-05-05","current":-44.071287,"twenty":-91.262492,"median":-44.99485,"eighty":-25.446669,"marketCap":1611246270},{"date":"2023-05-12","current":-56.561661,"twenty":-91.262492,"median":-45.21193,"eighty":-25.734923,"marketCap":1707596538},{"date":"2023-05-19","current":-58.984361,"twenty":-91.262492,"median":-45.264522,"eighty":-25.841782,"marketCap":1780737866},{"date":"2023-05-26","current":-61.143203,"twenty":-91.262492,"median":-45.56119,"eighty":-25.960414,"marketCap":1845913306},{"date":"2023-06-02","current":-62.822303,"twenty":-91.262492,"median":-45.690608,"eighty":-26.040937,"marketCap":1896605315},{"date":"2023-06-08","current":-63.421981,"twenty":-91.262492,"median":-45.878447,"eighty":-26.182052,"marketCap":1914709604},{"date":"2023-06-16","current":-63.613878,"twenty":-91.338153,"median":-46.043792,"eighty":-26.252633,"marketCap":1920502977},{"date":"2023-06-23","current":-63.565904,"twenty":-91.375983,"median":-46.661659,"eighty":-26.461667,"marketCap":1919054634},{"date":"2023-06-30","current":-62.030727,"twenty":-91.398369,"median":-46.819367,"eighty":-26.576376,"marketCap":1872707654},{"date":"2023-07-07","current":-55.698124,"twenty":-91.398369,"median":-46.977662,"eighty":-26.650444,"marketCap":1681526362},{"date":"2023-07-14","current":-68.411305,"twenty":-91.409562,"median":-47.534331,"eighty":-26.914684,"marketCap":2065337289},{"date":"2023-07-21","current":-67.211948,"twenty":-91.420755,"median":-47.73791,"eighty":-27.058428,"marketCap":2029128711},{"date":"2023-07-28","current":-65.340952,"twenty":-91.443299,"median":-47.926531,"eighty":-27.21209,"marketCap":1972643329},{"date":"2023-08-04","current":-61.119216,"twenty":-91.443299,"median":-48.35074,"eighty":-27.388744,"marketCap":1845189134},{"date":"2023-08-11","current":-63.688018,"twenty":-91.443299,"median":-48.910457,"eighty":-27.56212,"marketCap":1850773813},{"date":"2023-08-18","current":-61.034351,"twenty":-91.443299,"median":-49.678145,"eighty":-28.078838,"marketCap":1773658238},{"date":"2023-08-25","current":-62.861877,"twenty":-91.443299,"median":-50.719044,"eighty":-28.268442,"marketCap":1826766134},{"date":"2023-09-01","current":-66.09134,"twenty":-91.443299,"median":-51.572786,"eighty":-28.726088,"marketCap":1920614335},{"date":"2023-09-08","current":-63.412638,"twenty":-91.443299,"median":-52.145692,"eighty":-29.078669,"marketCap":1842771254},{"date":"2023-09-15","current":-63.112223,"twenty":-91.443299,"median":-52.482696,"eighty":-29.330892,"marketCap":1834041189},{"date":"2023-09-22","current":-56.578192,"twenty":-91.443299,"median":-52.696131,"eighty":-29.577122,"marketCap":1644162271},{"date":"2023-09-29","current":-57.354265,"twenty":-91.443299,"median":-53.606041,"eighty":-30.172229,"marketCap":1666714940},{"date":"2023-10-06","current":-53.448868,"twenty":-91.443299,"median":-53.774317,"eighty":-30.964578,"marketCap":1553224093},{"date":"2023-10-13","current":-52.622726,"twenty":-91.448974,"median":-54.089079,"eighty":-31.463943,"marketCap":1529216413},{"date":"2023-10-20","current":-52.04693,"twenty":-91.448974,"median":-54.089079,"eighty":-32.314481,"marketCap":1512483788},{"date":"2023-10-27","current":-51.12065,"twenty":-91.478337,"median":-54.190181,"eighty":-32.955566,"marketCap":1485566088},{"date":"2023-11-03","current":-55.952327,"twenty":-91.478337,"median":-54.259195,"eighty":-33.711668,"marketCap":1625974636},{"date":"2023-11-10","current":-31.391487,"twenty":-91.478337,"median":-54.312664,"eighty":-34.025402,"marketCap":1568161736},{"date":"2023-11-17","current":-36.128721,"twenty":-91.478337,"median":-54.312664,"eighty":-34.724031,"marketCap":1804810270},{"date":"2023-11-24","current":-38.292643,"twenty":-91.478337,"median":-54.312664,"eighty":-35.17226,"marketCap":1912908983},{"date":"2023-12-01","current":-37.429999,"twenty":-91.478337,"median":-54.312664,"eighty":-35.709925,"marketCap":1869815577},{"date":"2023-12-08","current":-36.581975,"twenty":-91.460325,"median":-54.297773,"eighty":-36.123643,"marketCap":1827452568},{"date":"2023-12-15","current":-41.59701,"twenty":-91.460325,"median":-54.297773,"eighty":-36.534748,"marketCap":2077978639},{"date":"2023-12-22","current":-40.953682,"twenty":-91.460325,"median":-54.297773,"eighty":-36.675157,"marketCap":2045841184},{"date":"2023-12-27","current":-41.7286,"twenty":-91.460325,"median":-54.297773,"eighty":-36.689994,"marketCap":2084552210},{"date":"2024-01-05","current":-37.342272,"twenty":-91.51436,"median":-54.527362,"eighty":-36.858194,"marketCap":1865433197},{"date":"2024-01-12","current":-39.389225,"twenty":-91.51436,"median":-54.527362,"eighty":-37.070317,"marketCap":1967688736},{"date":"2024-01-19","current":-37.356893,"twenty":-91.532372,"median":-54.58323,"eighty":-37.355359,"marketCap":1866163594},{"date":"2024-01-26","current":-38.044084,"twenty":-91.51436,"median":-54.527362,"eighty":-37.429999,"marketCap":1900492239},{"date":"2024-02-02","current":-37.079092,"twenty":-91.51436,"median":-54.527362,"eighty":-37.476327,"marketCap":1852286056},{"date":"2024-02-09","current":-36.552733,"twenty":-91.51436,"median":-54.527362,"eighty":-37.476327,"marketCap":1825991775},{"date":"2024-02-16","current":-36.991366,"twenty":-91.51436,"median":-54.527362,"eighty":-37.515454,"marketCap":1847903676},{"date":"2024-02-23","current":-23.893683,"twenty":-91.51436,"median":-54.527362,"eighty":-37.515454,"marketCap":1777785592},{"date":"2024-03-01","current":-23.76011,"twenty":-91.496349,"median":-54.420013,"eighty":-37.438772,"marketCap":1767847231},{"date":"2024-03-08","current":-22.952973,"twenty":-91.496349,"median":-54.420013,"eighty":-37.438772,"marketCap":1707792973},{"date":"2024-03-15","current":-21.449679,"twenty":-91.496349,"median":-54.420013,"eighty":-37.412453,"marketCap":1595941916},{"date":"2024-03-22","current":-21.762445,"twenty":-91.496349,"median":-54.420013,"eighty":-37.336424,"marketCap":1619212942},{"date":"2024-03-28","current":-21.913783,"twenty":-91.496349,"median":-54.420013,"eighty":-37.186712,"marketCap":1630473115},{"date":"2024-04-05","current":-20.349954,"twenty":-91.51436,"median":-54.527362,"eighty":-36.91826,"marketCap":1514117989},{"date":"2024-04-12","current":-20.91495,"twenty":-91.51436,"median":-54.527362,"eighty":-36.816545,"marketCap":1556155970},{"date":"2024-04-19","current":-19.3713,"twenty":-91.51436,"median":-54.527362,"eighty":-36.630648,"marketCap":1441302201},{"date":"2024-04-26","current":-20.01504,"twenty":-91.496349,"median":-54.420013,"eighty":-36.570278,"marketCap":1489199053},{"date":"2024-05-03","current":-20.744541,"twenty":-91.496349,"median":-54.224688,"eighty":-36.251538,"marketCap":1543476842},{"date":"2024-05-10","current":-23.132782,"twenty":-91.496349,"median":-53.830116,"eighty":-35.868466,"marketCap":1577123684},{"date":"2024-05-17","current":-26.238832,"twenty":-91.496349,"median":-53.653277,"eighty":-35.501067,"marketCap":1788884838},{"date":"2024-05-24","current":-23.368259,"twenty":-91.496349,"median":-53.355546,"eighty":-34.872412,"marketCap":1593177778},{"date":"2024-05-31","current":-23.536456,"twenty":-91.496349,"median":-52.709497,"eighty":-33.901589,"marketCap":1604644989},{"date":"2024-06-07","current":-24.00741,"twenty":-91.496349,"median":-52.595031,"eighty":-33.456179,"marketCap":1636753178},{"date":"2024-06-14","current":-24.43351,"twenty":-91.51436,"median":-52.26926,"eighty":-32.638648,"marketCap":1665803445},{"date":"2024-06-21","current":-24.399871,"twenty":-91.532372,"median":-52.100758,"eighty":-32.295091,"marketCap":1663510003},{"date":"2024-06-28","current":-24.657774,"twenty":-91.613549,"median":-51.946792,"eighty":-31.731749,"marketCap":1681093059},{"date":"2024-07-05","current":-24.074689,"twenty":-91.613549,"median":-51.12065,"eighty":-31.356669,"marketCap":1641340062},{"date":"2024-07-12","current":-25.308138,"twenty":-91.613549,"median":-50.662876,"eighty":-30.584177,"marketCap":1725432939},{"date":"2024-07-15","current":-25.509975,"twenty":-91.613549,"median":-50.619958,"eighty":-30.376556,"marketCap":1739193592},{"date":"2024-08-02","current":-25.734239,"twenty":-91.460325,"median":-49.281162,"eighty":-30.057472,"marketCap":1754483206},{"date":"2024-08-09","current":-42.598386,"twenty":-90.077119,"median":-48.628371,"eighty":-29.971094,"marketCap":2302059356},{"date":"2024-08-16","current":-46.421864,"twenty":-89.655421,"median":-48.296183,"eighty":-29.971094,"marketCap":2508683969},{"date":"2024-08-23","current":-44.147676,"twenty":-88.628983,"median":-47.792212,"eighty":-29.971094,"marketCap":2385784571},{"date":"2024-08-30","current":-45.39848,"twenty":-87.513126,"median":-47.536017,"eighty":-29.971094,"marketCap":2453379240},{"date":"2024-09-06","current":-42.314112,"twenty":-86.96433,"median":-46.977662,"eighty":-29.971094,"marketCap":2286696931},{"date":"2024-09-13","current":-43.238001,"twenty":-86.01184,"median":-46.789766,"eighty":-29.971094,"marketCap":2336624812},{"date":"2024-09-20","current":-50.103206,"twenty":-85.352102,"median":-46.781191,"eighty":-29.971094,"marketCap":2707627371},{"date":"2024-09-27","current":-47.630027,"twenty":-84.105714,"median":-46.781191,"eighty":-29.971094,"marketCap":2573974275},{"date":"2024-10-04","current":-46.862488,"twenty":-82.553824,"median":-46.781191,"eighty":-29.971094,"marketCap":2532495728},{"date":"2024-10-11","current":-45.867531,"twenty":-80.968196,"median":-46.676355,"eighty":-29.971094,"marketCap":2478727241},{"date":"2024-10-18","current":-48.767121,"twenty":-79.854884,"median":-46.676355,"eighty":-29.971094,"marketCap":2635423974},{"date":"2024-10-25","current":-46.592428,"twenty":-78.335923,"median":-46.62248,"eighty":-29.971094,"marketCap":2517901424},{"date":"2024-10-31","current":-49.747864,"twenty":-76.94338,"median":-46.62248,"eighty":-29.971094,"marketCap":2688424340},{"date":"2024-11-08","current":-309.469649,"twenty":-76.100367,"median":-46.592428,"eighty":-29.902465,"marketCap":2868164710},{"date":"2024-11-15","current":-309.73093,"twenty":-76.100367,"median":-46.592428,"eighty":-29.902465,"marketCap":2870586258},{"date":"2024-11-22","current":-325.618856,"twenty":-76.100367,"median":-46.592428,"eighty":-29.902465,"marketCap":3017835553},{"date":"2024-11-29","current":-359.150741,"twenty":-76.100367,"median":-46.592428,"eighty":-29.902465,"marketCap":3328609065},{"date":"2024-12-06","current":-358.230913,"twenty":-76.100367,"median":-46.592428,"eighty":-29.902465,"marketCap":3320084106},{"date":"2024-12-13","current":-371.275737,"twenty":-76.100367,"median":-46.592428,"eighty":-29.902465,"marketCap":3440983527},{"date":"2024-12-20","current":-326.705924,"twenty":-76.100367,"median":-46.592428,"eighty":-29.902465,"marketCap":3027910505},{"date":"2024-12-27","current":-342.426608,"twenty":-76.100367,"median":-46.592428,"eighty":-29.902465,"marketCap":3173609807},{"date":"2025-01-03","current":-338.161955,"twenty":-76.100367,"median":-46.592428,"eighty":-29.902465,"marketCap":3134084996},{"date":"2025-01-10","current":-366.091256,"twenty":-75.921084,"median":-46.507146,"eighty":-29.833836,"marketCap":3392933757},{"date":"2025-01-17","current":-343.680918,"twenty":-75.921084,"median":-46.507146,"eighty":-29.833836,"marketCap":3185234751},{"date":"2025-01-24","current":-368.516255,"twenty":-75.921084,"median":-46.507146,"eighty":-29.833836,"marketCap":3415408650},{"date":"2025-01-31","current":-385.825732,"twenty":-75.921084,"median":-46.507146,"eighty":-29.833836,"marketCap":3575832882},{"date":"2025-02-07","current":-363.749877,"twenty":-75.921084,"median":-46.507146,"eighty":-29.833836,"marketCap":3371233861},{"date":"2025-02-14","current":-331.054199,"twenty":-75.921084,"median":-46.507146,"eighty":-29.833836,"marketCap":3068210312},{"date":"2025-02-21","current":-343.262815,"twenty":-75.921084,"median":-46.507146,"eighty":-29.833836,"marketCap":3181359770},{"date":"2025-02-28","current":108.649741,"twenty":-74.081284,"median":-46.271091,"eighty":-29.512355,"marketCap":2622587445},{"date":"2025-03-07","current":104.979059,"twenty":-72.01026,"median":-45.967027,"eighty":-29.191754,"marketCap":2533984537},{"date":"2025-03-14","current":98.262466,"twenty":-70.793997,"median":-45.867531,"eighty":-28.823085,"marketCap":2371859411},{"date":"2025-03-21","current":102.815541,"twenty":-69.1693,"median":-45.622558,"eighty":-28.456761,"marketCap":2481761540},{"date":"2025-03-28","current":100.425984,"twenty":-68.497658,"median":-45.480226,"eighty":-28.150052,"marketCap":2424082409},{"date":"2025-04-04","current":91.933369,"twenty":-67.841872,"median":-45.225885,"eighty":-27.678468,"marketCap":2219087658},{"date":"2025-04-11","current":97.681223,"twenty":-67.419943,"median":-45.18393,"eighty":-27.388744,"marketCap":2357829353},{"date":"2025-04-17","current":101.814511,"twenty":-66.902461,"median":-44.998331,"eighty":-27.21209,"marketCap":2457598661},{"date":"2025-04-25","current":103.784281,"twenty":-65.995926,"median":-44.823627,"eighty":-27.013515,"marketCap":2505144972},{"date":"2025-05-02","current":95.937492,"twenty":-65.68518,"median":-44.534449,"eighty":-26.71491,"marketCap":2315739176},{"date":"2025-05-09","current":73.607563,"twenty":-65.460728,"median":-44.285561,"eighty":-26.514847,"marketCap":2432656334},{"date":"2025-05-16","current":67.51137,"twenty":-65.460728,"median":-44.147676,"eighty":-26.313901,"marketCap":2231183267},{"date":"2025-05-23","current":64.92845,"twenty":-65.460728,"median":-43.986895,"eighty":-26.2045,"marketCap":2145820341},{"date":"2025-05-30","current":63.885803,"twenty":-65.460728,"median":-43.84417,"eighty":-26.011175,"marketCap":2111361912},{"date":"2025-06-06","current":63.933196,"twenty":-65.460728,"median":-43.736605,"eighty":-25.918892,"marketCap":2112928204},{"date":"2025-06-13","current":63.245997,"twenty":-65.460728,"median":-43.5521,"eighty":-25.777549,"marketCap":2090216967},{"date":"2025-06-20","current":63.554052,"twenty":-65.500654,"median":-43.38443,"eighty":-25.669802,"marketCap":2100397867},{"date":"2025-06-27","current":63.530356,"twenty":-65.500654,"median":-43.238236,"eighty":-25.459026,"marketCap":2099614720},{"date":"2025-07-03","current":65.189112,"twenty":-65.500654,"median":-43.101676,"eighty":-25.399624,"marketCap":2154434948},{"date":"2025-07-11","current":65.212808,"twenty":-65.13962,"median":-43.022282,"eighty":-25.2232,"marketCap":2155218094},{"date":"2025-07-18","current":57.392958,"twenty":-64.831855,"median":-42.801885,"eighty":-25.094253,"marketCap":1896779878},{"date":"2025-07-25","current":55.900078,"twenty":-64.170379,"median":-42.572884,"eighty":-24.86584,"marketCap":1847441673},{"date":"2025-08-01","current":55.710506,"twenty":-63.698031,"median":-42.387461,"eighty":-24.663707,"marketCap":1841176504},{"date":"2025-08-08","current":82.314351,"twenty":-63.698031,"median":-42.228474,"eighty":-24.536015,"marketCap":2167748432},{"date":"2025-08-15","current":89.739681,"twenty":-63.683011,"median":-41.983994,"eighty":-24.436829,"marketCap":2363294503},{"date":"2025-08-22","current":87.917404,"twenty":-63.604283,"median":-41.904528,"eighty":-24.392203,"marketCap":2315304834},{"date":"2025-08-29","current":89.470821,"twenty":-63.604283,"median":-41.69712,"eighty":-24.297955,"marketCap":2356214060},{"date":"2025-09-05","current":94.160944,"twenty":-63.613878,"median":-41.603428,"eighty":-24.214125,"marketCap":2479728453},{"date":"2025-09-12","current":95.176639,"twenty":-63.604283,"median":-41.374581,"eighty":-24.074689,"marketCap":2506476793},{"date":"2025-09-19","current":99.269294,"twenty":-63.604283,"median":-41.324883,"eighty":-23.980498,"marketCap":2614256869},{"date":"2025-09-26","current":98.044485,"twenty":-63.604283,"median":-41.209332,"eighty":-23.877018,"marketCap":2582001518},{"date":"2025-10-03","current":106.438909,"twenty":-63.604283,"median":-40.99355,"eighty":-23.745326,"marketCap":2803068680},{"date":"2025-10-10","current":104.347772,"twenty":-63.420112,"median":-40.758268,"eighty":-23.63403,"marketCap":2747998568},{"date":"2025-10-17","current":106.976631,"twenty":-63.272444,"median":-40.643374,"eighty":-23.433295,"marketCap":2817229566},{"date":"2025-10-24","current":106.468783,"twenty":-62.853962,"median":-40.427789,"eighty":-23.325552,"marketCap":2803855396},{"date":"2025-10-31","current":105.542708,"twenty":-62.539254,"median":-40.30981,"eighty":-23.161544,"marketCap":2779467204},{"date":"2025-11-07","current":108.703368,"twenty":-62.15546,"median":-40.156833,"eighty":-22.993014,"marketCap":3295560022},{"date":"2025-11-14","current":103.957863,"twenty":-62.02593,"median":-40.011843,"eighty":-22.899523,"marketCap":3151690527},{"date":"2025-11-21","current":106.513135,"twenty":-61.570174,"median":-39.830951,"eighty":-22.543606,"marketCap":3229158717},{"date":"2025-11-28","current":123.435295,"twenty":-61.276626,"median":-39.607499,"eighty":-22.439091,"marketCap":3742187849},{"date":"2025-12-05","current":123.617815,"twenty":-60.812292,"median":-39.479062,"eighty":-21.93391,"marketCap":3747721291},{"date":"2025-12-12","current":110.085301,"twenty":-59.775937,"median":-39.400551,"eighty":-21.779192,"marketCap":3337456084},{"date":"2025-12-19","current":109.615966,"twenty":-59.004338,"median":-39.267171,"eighty":-21.519912,"marketCap":3323227232},{"date":"2025-12-26","current":111.519383,"twenty":-58.495474,"median":-39.054032,"eighty":-21.28018,"marketCap":3380933129},{"date":"2026-01-02","current":109.772411,"twenty":-57.924181,"median":-38.880192,"eighty":-20.900716,"marketCap":3327970183},{"date":"2026-01-09","current":113.579245,"twenty":-57.32923,"median":-38.729689,"eighty":-20.703299,"marketCap":3443381975},{"date":"2026-01-16","current":106.904248,"twenty":-56.699295,"median":-38.54973,"eighty":-20.469262,"marketCap":3241016093},{"date":"2026-01-23","current":114.205026,"twenty":-56.465991,"median":-38.401246,"eighty":-20.358769,"marketCap":3462353777},{"date":"2026-01-30","current":101.011477,"twenty":-55.980492,"median":-38.30969,"eighty":-20.037188,"marketCap":3062364962},{"date":"2026-02-06","current":90.894685,"twenty":-55.650411,"median":-38.264113,"eighty":-19.55896,"marketCap":2755654170},{"date":"2026-02-13","current":91.650837,"twenty":-54.962607,"median":-38.122272,"eighty":39.852805,"marketCap":2778578430},{"date":"2026-02-20","current":94.597223,"twenty":-54.264343,"median":-38.015912,"eighty":55.862164,"marketCap":2867903996},{"date":"2026-02-27","current":46.164536,"twenty":-53.85672,"median":-37.966951,"eighty":57.255519,"marketCap":3063155453},{"date":"2026-03-06","current":41.529671,"twenty":-53.597054,"median":-37.842225,"eighty":57.255519,"marketCap":2755618248},{"date":"2026-03-13","current":37.039006,"twenty":-52.755398,"median":-37.689456,"eighty":57.255519,"marketCap":2457649147},{"date":"2026-03-20","current":39.254401,"twenty":-52.601771,"median":-37.637989,"eighty":57.255519,"marketCap":2604647237},{"date":"2026-03-27","current":39.278351,"twenty":-52.251287,"median":-37.571876,"eighty":57.255519,"marketCap":2606236405},{"date":"2026-04-02","current":38.799346,"twenty":-52.114238,"median":-37.437309,"eighty":57.255519,"marketCap":2574453034},{"date":"2026-04-10","current":37.54196,"twenty":-51.811908,"median":-37.355935,"eighty":57.255519,"marketCap":2491021686},{"date":"2026-04-17","current":39.553778,"twenty":-50.802171,"median":-37.246652,"eighty":57.255519,"marketCap":2624511843},{"date":"2026-04-24","current":39.697479,"twenty":-50.055625,"median":-36.954813,"eighty":57.255519,"marketCap":2634046855},{"date":"2026-05-01","current":39.587632,"twenty":-49.711179,"median":-36.817494,"eighty":57.255519,"marketCap":2626758137},{"date":"2026-05-08","current":36.953044,"twenty":-49.34063,"median":-36.67701,"eighty":57.255519,"marketCap":3252348291},{"date":"2026-05-15","current":35.266767,"twenty":-49.34063,"median":-36.581975,"eighty":57.255519,"marketCap":3103933968},{"date":"2026-05-22","current":40.969285,"twenty":-49.34063,"median":-36.356139,"eighty":57.255519,"marketCap":3605829717},{"date":"2026-05-29","current":43.507767,"twenty":-49.349881,"median":-35.977855,"eighty":57.369262,"marketCap":3829249129},{"date":"2026-06-05","current":45.275639,"twenty":-49.34063,"median":-35.733952,"eighty":57.255519,"marketCap":3984844791},{"date":"2026-06-12","current":42.991005,"twenty":-49.34063,"median":-35.325087,"eighty":57.255519,"marketCap":3783767320},{"date":"2026-06-18","current":46.49955,"twenty":-49.34063,"median":-34.436594,"eighty":57.255519,"marketCap":4092564864},{"date":"2026-06-26","current":53.081471,"twenty":-49.349881,"median":-33.57374,"eighty":57.369262,"marketCap":4671859481},{"date":"2026-07-02","current":54.260052,"twenty":-49.349881,"median":-33.033337,"eighty":57.369262,"marketCap":4775589922},{"date":"2026-07-10","current":53.761421,"twenty":-49.349881,"median":-32.372651,"eighty":57.369262,"marketCap":4731703967},{"date":"2026-07-17","current":53.688893,"twenty":-49.349881,"median":-31.565405,"eighty":57.369262,"marketCap":4725320555},{"date":"2026-07-24","current":52.474048,"twenty":-49.349881,"median":-31.141244,"eighty":57.369262,"marketCap":4618398408},{"date":"2026-07-31","current":41.665614,"twenty":-49.35355,"median":-30.375408,"eighty":57.374001,"marketCap":4770004437},{"date":"2026-08-07","current":32.40684,"twenty":-49.222748,"median":-29.992215,"eighty":57.374001,"marketCap":3710032235},{"date":"2026-08-14","current":29.914006,"twenty":-48.918745,"median":-29.50942,"eighty":57.374001,"marketCap":3424645140},{"date":"2026-08-21","current":29.345218,"twenty":-48.918745,"median":-29.203367,"eighty":57.374001,"marketCap":3359528648}],"updateTime":1787583039637},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"VCYT\",pageSize:20,pageCount:3,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2644103022","title":"Veracyte (VCYT) Stock Could Be 4.5% Overvalued After Its Recent Run","url":"https://stock-news.laohu8.com/highlight/detail?id=2644103022","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2644103022?lang=en_us&edition=fundamental","pubTime":"2026-06-19 10:39","pubTimestamp":1781836772,"startTime":"0","endTime":"0","summary":"Veracyte (VCYT) has drawn attention after recent share price gains over the past month and the past 3 months, prompting a closer look at how its diagnostics business and current valuation might align with investor expectations.\nSee our latest analysis for Veracyte.\nAt a share price of $51.29, Veracyte has seen short term momentum build, with a 30 day share price return of 23.59% feeding into a 1 year total shareholder return of 91.24% and a 3 year total shareholder return of 98.34%.\nIf...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-vcyt/veracyte/news/veracyte-vcyt-stock-could-be-45-overvalued-after-its-recent","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-vcyt/veracyte/news/veracyte-vcyt-stock-could-be-45-overvalued-after-its-recent","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["VCYT","BK4139","DCF"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642237521","title":"Veracyte shareholders endorse board, pay and incentive plans","url":"https://stock-news.laohu8.com/highlight/detail?id=2642237521","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642237521?lang=en_us&edition=fundamental","pubTime":"2026-06-12 06:10","pubTimestamp":1781215825,"startTime":"0","endTime":"0","summary":"Veracyte ( ($VCYT) ) has provided an update. At its recent annual meeting, Veracyte stockholders elected nine directors, including Eliav Barr, Muna...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/veracyte-shareholders-endorse-board-pay-and-incentive-plans?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/veracyte-shareholders-endorse-board-pay-and-incentive-plans?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","VCYT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642234581","title":"Veracyte shareholders approve 3.5 million-share increase to 2023 equity plan at annual meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2642234581","media":"Reuters","labels":["executive","shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642234581?lang=en_us&edition=fundamental","pubTime":"2026-06-12 04:33","pubTimestamp":1781210021,"startTime":"0","endTime":"0","summary":"Veracyte held its annual shareholder meeting on June 10, 2026.Shareholders ratified Ernst & Young as independent registered public accounting firm for fiscal 2026.Shareholders authorized an amendment to the 2023 Equity Incentive Plan, increasing shares reserved for issuance by 3.5 million.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Veracyte Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on June 11, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260611:nNDL3mBVtM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive,shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VCYT","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641196448","title":"Veracyte EVP, General Counsel Annie McGuire disposes of common shares worth $159,490","url":"https://stock-news.laohu8.com/highlight/detail?id=2641196448","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2641196448?lang=en_us&edition=fundamental","pubTime":"2026-06-05 09:39","pubTimestamp":1780623578,"startTime":"0","endTime":"0","summary":"Veracyte EVP and General Counsel Annie McGuire cut her stake through share disposals in early June.Sold 3,176 shares on June 4 at weighted average prices of USD 49.31 and USD 50.12.Withheld 3,292 shares on June 2 at USD 47.8 to cover tax obligations tied to RSU vesting.Beneficial ownership fell to 137,240 shares following the reported transactions.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Veracyte Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on June 04, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260605:nNDL8T46K1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Veracyte EVP, General Counsel Annie McGuire disposes of common shares worth $159,490","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VCYT","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641196446","title":"Veracyte CFO Rebecca Chambers disposes of 3,561 common shares worth $177,866.63","url":"https://stock-news.laohu8.com/highlight/detail?id=2641196446","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2641196446?lang=en_us&edition=fundamental","pubTime":"2026-06-05 09:39","pubTimestamp":1780623568,"startTime":"0","endTime":"0","summary":"Veracyte CFO Rebecca Chambers cut her stake, ending with 173,280 common shares as of June 4, 2026.Sold 3,561 shares on June 4 at weighted average prices of $49.28 and $50.09.Withheld 3,693 shares on June 2 at $47.8 to cover tax obligations tied to restricted stock unit vesting.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Veracyte Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on June 04, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260605:nNDL4Kr55q:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","VCYT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641196449","title":"Veracyte CEO Marc Stapley disposes of common shares worth $7.35 million","url":"https://stock-news.laohu8.com/highlight/detail?id=2641196449","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2641196449?lang=en_us&edition=fundamental","pubTime":"2026-06-05 09:39","pubTimestamp":1780623553,"startTime":"0","endTime":"0","summary":"Veracyte CEO Marc Stapley cut his stake through a 138,051-share sale on June 4 at USD 50.12 a share.The sale followed the exercise of a stock option for 138,051 shares at USD 36.6 on June 4.Stapley also surrendered 9,012 shares on June 2 at USD 47.8.He reported 440,494 Veracyte common shares owned after the transactions.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Veracyte Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on June 04, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260605:nNDL8Q04lr:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VCYT","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641964411","title":"Veracyte Global Chief Commercial Officer John Leite disposes of USD 700,732 in common shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2641964411","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2641964411?lang=en_us&edition=fundamental","pubTime":"2026-06-05 09:39","pubTimestamp":1780623551,"startTime":"0","endTime":"0","summary":"Veracyte Global Chief Commercial Officer John Leite reported a reduction in his common stock stake in early June 2026.Leite sold 13,975 shares on June 4 at an average price of $50.07, leaving 132,305 shares.He also disposed of 4,059 shares on June 2 at $47.8, leaving 146,280 shares before the later sale.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Veracyte Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on June 04, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260605:nNDL6gfMbd:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VCYT","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640928355","title":"Veracyte posts investor presentation outlining growth strategy for genomic cancer diagnostics portfolio","url":"https://stock-news.laohu8.com/highlight/detail?id=2640928355","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640928355?lang=en_us&edition=fundamental","pubTime":"2026-06-03 03:04","pubTimestamp":1780427050,"startTime":"0","endTime":"0","summary":"Veracyte outlined plans to launch the Prosigna LDT on June 8, 2026, targeting ER+/HER2- breast cancer patients.Management framed the eligible US population at about 225,000 newly diagnosed ER+/HER2- breast cancer cases annually.The presentation highlighted OPTIMA as supporting Prosigna-directed chemotherapy decisions in a broad high-risk patient group.Prosigna clinical evidence base cited 157 breast-related publications, described as growing.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Veracyte Inc. published the original content used to generate this news brief on June 02, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260602:nNDL2Wf1h9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VCYT","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640748917","title":"Needham Raises Price Target on Veracyte to $57 From $48, Keeps Buy Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2640748917","media":"MT Newswires Live","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640748917?lang=en_us&edition=fundamental","pubTime":"2026-06-02 19:29","pubTimestamp":1780399740,"startTime":"0","endTime":"0","summary":"Veracyte (VCYT) has an average rating of overweight and mean price target of $48.80, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from major ban","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate","earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["VCYT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640627909","title":"Veracyte assumed with an Outperform at Wolfe Research","url":"https://stock-news.laohu8.com/highlight/detail?id=2640627909","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640627909?lang=en_us&edition=fundamental","pubTime":"2026-06-02 04:47","pubTimestamp":1780346840,"startTime":"0","endTime":"0","summary":"Wolfe Research assumed coverage of Veracyte (VCYT) with an Outperform rating and price target of $55, up from $50. The company’s testing assets, Af...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/veracyte-assumed-with-an-outperform-at-wolfe-research-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/veracyte-assumed-with-an-outperform-at-wolfe-research-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["VCYT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640680439","title":"Veracyte Is Maintained at Buy by Needham","url":"https://stock-news.laohu8.com/highlight/detail?id=2640680439","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640680439?lang=en_us&edition=fundamental","pubTime":"2026-06-01 23:32","pubTimestamp":1780327920,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/VCYT/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  June 01, 2026 11:32 ET (15:32 GMT)","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VCYT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640974968","title":"Veracyte Inc : Needham Raises Target Price to $57 From $48","url":"https://stock-news.laohu8.com/highlight/detail?id=2640974968","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640974968?lang=en_us&edition=fundamental","pubTime":"2026-06-01 23:07","pubTimestamp":1780326461,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260601:nFWN4290OF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["VCYT","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640517639","title":"Veracyte posts investor presentation on ASCO findings","url":"https://stock-news.laohu8.com/highlight/detail?id=2640517639","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640517639?lang=en_us&edition=fundamental","pubTime":"2026-06-01 20:34","pubTimestamp":1780317278,"startTime":"0","endTime":"0","summary":"Veracyte published an investor presentation highlighting ASCO data on Prosigna in the OPTIMA phase III trial for ER-positive, HER2-negative early breast cancer.In the per-protocol ROR ≤60 group, 5-year invasive breast cancer-free survival was 93.6% in the test-directed arm versus 94.8% in the control arm.Adjusted hazard ratio was 1.06 with a 90% CI of 0.80-1.40; non-inferiority met with p=0.003.Across the broader low-risk analysis shown, 5-year invasive breast cancer-free survival was 90.3% versus 91.8%; adjusted hazard ratio 1.03, 90% CI 0.85-1.25.Presentation also cited Decipher evidence in metastatic prostate cancer from ENZAMET, using DGC >0.85 to identify docetaxel benefit with ADT, enzalutamide.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or l","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260601:nNDL2thmt0:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VCYT","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2639480988","title":"Veracyte announces results from Enzamet trial presented at 2026 ASCO meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2639480988","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2639480988?lang=en_us&edition=fundamental","pubTime":"2026-05-31 21:36","pubTimestamp":1780234597,"startTime":"0","endTime":"0","summary":"Veracyte (VCYT) announced results from the Enzamet trial presented at the 2026 ASCO Annual Meeting. The analysis demonstrates that the Decipher Pro...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/veracyte-announces-results-from-enzamet-trial-presented-at-2026-asco-meeting-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/veracyte-announces-results-from-enzamet-trial-presented-at-2026-asco-meeting-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","VCYT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2639515609","title":"Veracyte - Enzamet Trial Shows Decipher Prostate Test Identifies Chemotherapy Benefit in Metastatic Prostate Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2639515609","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2639515609?lang=en_us&edition=fundamental","pubTime":"2026-05-30 20:10","pubTimestamp":1780143023,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260530:nFWN4261DV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","VCYT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2639582609","title":"Veracyte says ENZAMET trial shows Decipher Prostate test flags metastatic patients who benefit from adding docetaxel","url":"https://stock-news.laohu8.com/highlight/detail?id=2639582609","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2639582609?lang=en_us&edition=fundamental","pubTime":"2026-05-30 20:00","pubTimestamp":1780142431,"startTime":"0","endTime":"0","summary":"Veracyte disclosed results already presented at the 2026 ASCO meeting from a biomarker analysis of the Phase III ENZAMET trial.The Decipher Prostate test identified metastatic prostate cancer patients likely to benefit from adding docetaxel to standard hormonal therapy.Patients with lower-risk genomic profiles showed no added benefit from chemotherapy, supporting treatment de-escalation in that group.The readout positions Decipher as a decision tool for selecting triplet therapy, potentially expanding clinical adoption in advanced disease.Separate ASCO data in high-risk localized disease supported broader use by improving risk stratification beyond standard clinical factors.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260530:nNDL6Dvgjh:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","VCYT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2639672488","title":"Veracyte Says Prosigna Test Can Help High-Risk Breast Cancer Patients Avoid Chemotherapy","url":"https://stock-news.laohu8.com/highlight/detail?id=2639672488","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2639672488?lang=en_us&edition=fundamental","pubTime":"2026-05-30 04:00","pubTimestamp":1780084814,"startTime":"0","endTime":"0","summary":"Veracyte  said results from an independent Phase 3 trial show its Prosigna Breast Risk of Recurrence test can safely guide adjuvant chemotherapy decisions for patients with early-stage, ER-positive, HER2-negative breast cancer.The study, led by University College London, enrolled 4,429 patients and had a median follow-up of four years, Veracyte said Friday in a statement. Investigators reported that Prosigna provided Level 1A evidence, demonstrating the test can accurately predict chemotherapy benefit and support safe treatment de-escalation across high-risk groups.The results will be presented Saturday at the annual meeting of the American Society of Clinical Oncology.Price: 46.32, Change: -1.67, Percent Change: -3.48","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["VCYT","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2639767442","title":"Veracyte says OPTIMA trial shows Prosigna test helps 68% of high-risk breast cancer patients avoid chemotherapy","url":"https://stock-news.laohu8.com/highlight/detail?id=2639767442","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2639767442?lang=en_us&edition=fundamental","pubTime":"2026-05-30 03:15","pubTimestamp":1780082122,"startTime":"0","endTime":"0","summary":"Veracyte announced OPTIMA Phase III trial results for its Prosigna breast cancer test, with findings set for presentation May 30 at ASCO 2026.The study found the test can guide treatment choices so many clinically high-risk early-stage patients can skip chemotherapy without worsening outcomes.Results support wider adoption of Prosigna to reduce chemotherapy use in hormone receptor-positive, HER2-negative breast cancer, including node-positive disease.Veracyte framed the data as the strongest prospective evidence for Prosigna in predicting chemotherapy benefit, strengthening its competitive position in genomic testing.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Veracyte Inc. published the original content used to generate this news ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260529:nNDL37tNkT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","VCYT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2639467425","title":"Veracyte - Optima Trial Shows Prosigna Test Identifies High-Risk Breast Cancer Patients Who Can Avoid Chemotherapy","url":"https://stock-news.laohu8.com/highlight/detail?id=2639467425","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2639467425?lang=en_us&edition=fundamental","pubTime":"2026-05-30 03:15","pubTimestamp":1780082117,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260529:nFWN4261MR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","VCYT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638431662","title":"Veracyte Price Target Maintained With a $48.00/Share by Needham","url":"https://stock-news.laohu8.com/highlight/detail?id=2638431662","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638431662?lang=en_us&edition=fundamental","pubTime":"2026-05-28 18:39","pubTimestamp":1779964740,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/VCYT/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  May 28, 2026 06:39 ET (10:39 GMT)","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VCYT"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":7,"pageCount":3,"totalSize":129,"code":"91000000","status":"200"}]}}